baber/WOPTO huggingface dataset:
Patent ES-8504635-A1 (ES)
Title: Reducing scale formation in brine distn. appts.
IPC: C02F5/08
Filed: 1984-05-16
Abstract: Formation of alkaline scale on equipment surfaces in contact with an evaporating alkaline brine, which contains at least one high temp. chemical scale control additive capable of threshold scale inhibition, is reduced or eliminated by adding to the brine sufficient carbon dioxide to reduce the extent of bicarbonate decompsn. yet sufficient to result in high levels of uncombined carbon dioxide in the brine. The method is esp. useful in distillation plant for seawater or brackish water. It allows the appts. to be operated for long periods between shutdowns for cleaning, without exacerbating corrosion problems.
Patent ES-8602898-A1 (ES)
Title: Adhesive composition resistant to biological fluids.
IPC: C08L23/00
Filed: 1984-06-26
Abstract: Medical grade pressure sensitive adhesive compositions comprising a homogeneous mixture of one or more polyisobutylenes or blends of one or more polyisobutylenes and butyl rubber, one or more styrene radial or block type copolymers, mineral oil, one or more water soluble hydrocolloid gums, and a tackifier. One or more water swellable cohesive strengthening agents, an antioxidant, and various other optional ingredients may be included within the adhesive composition.
Patent ES-8606217-A1 (ES)
Title: Decoration for objects such as glass flasks or bottles
IPC: C04B41/45
Filed: 1984-07-12
Abstract: The invention relates to the flask- or bottle-making industry. It is proposed to produce a decoration by depositing on the substrate first of all a sublayer which has exactly the contours of the final decoration, then a final layer which adheres to the lower substrate which adheres to the sublayer, so as to overlap at least all the surface of the sublayer, then in removing any overspill of the final layer with respect to the sublayer. The invention makes it possible to produce very delicate inscriptions and in general decorations which have a good appearance on glass objects such as flasks or bottles.
Patent ES-8601279-A1 (ES)
Title: Storage-stable one-component compositions based on polymers containing a mercapto group.
IPC: C08L81/04
Filed: 1984-08-10
Abstract: One component compsn. contains mercaptor gp.-contg. polymers, standard additives and, in homogeneous distribution and in direct contact, (A) metal oxides of elements of Periodic System main Gp. IV or II or of side-Gp. VII, in an amt. leading to a partial crosslinking, and (B) metal peroxides of elements of main- and/or side-Gp. II, which effect the crosslinking of the remaining mercapto gps. (A) is esp. PbO and (B) CaO2. Wt. ratio (A):(B) is 1: 99 to 99: 1. The total amt. of (A) and (B) may be 3-10 wt.%.
Patent ES-8603563-A1 (ES)
Title: Free-flowing particulate fabric-softening adjunct for use in laundry detergent compositions and method of making same.
IPC: D06M13/328
Filed: 1984-08-24
Abstract: Free-flowing particulate fabric-softening adjunct for use in laundry detergent compsns. comprises NaBO3.H2O2 (I) on which is absorbed 5-100 % of its wt. of a fabric softening agent (II). (II) is an organic prim., sec., tert., or quat. N cpd. or phosphonium or sulphonium cpd. which has at least one 6-22C hydrocarbon gp. conferring hydrophobicity and lubricity. - Pref. adjunct contains 50-85 % by wt. of (I) and 50-15 % by wt. of (II). (I) pref. has average particle dia. 350-450 microns.
Patent ES-8602724-A1 (ES)
Title: Derivatives of 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phenyl acetamide, their preparation and their therapeutical use.
IPC: A61P9/08
Filed: 1984-09-13
Abstract: 1. Compounds of the formula : see diagramm : EP0143016,P9,F1 wherein R1 represents hydrogen or an alkyl radical linear or branched having 1-6 C atoms R2 and R3 represent separately a phenyl radical, an alkyl radical linear or branched having 1-6 C atoms, or together with the carbon atom to which they are bounded a cycloalkyl radical of 5 to 7 C atoms R4 represents hydrogen or an alkyl radical linear or branched having 1-6 C atoms R5 represents an alkyl radical linear or branched having 1-6 C atoms or phenyl radical optionally substituted by a halogen atom X represents hydrogen or halogen atom, and pharmaceutically acceptable addition salts thereof.
Patent ES-8702024-A1 (ES)
Title: Hydride blister-resistant zirconium-based nuclear fuel rod cladding.
IPC: G21C3/20
Filed: 1985-05-06
Abstract: Nuclear fuel rod (1) including a tubular cladding (3) formed from a zirconium-based alloy which has a thin film (17, 27) of nickel metal or a nickel base zirconium alloy, of a thickness of from 0.01 to 5 microns, distributed over from 1-40 percent of the area of its internal surface (21). The dispersed film (17, 27) provides multiple sites for hydride transport from the interior of the nuclear fuel rod (1).
Patent ES-8703524-A1 (ES)
Title: Externalization of products of bacteria.
IPC: C12N15/73
Filed: 1985-05-16
Abstract: A bacterial product is made by transforming a temperature sensitive lysogen with a DNA molecule which codes, directly or indirectly, for the product, culturing the transformant under permissive conditions and externalizing the product by raising the temperature to induce phage encoded functions.
Patent ES-8800074-A1 (ES)
Title: Preparation of monolithic support structures containing high surface area agglomerates.
IPC: B01J37/00
Filed: 1986-03-18
Abstract: Monolithic catalyst support structures in which a support phase of high surface area oxide material is disposed on or within a sintered ceramic material are improved by using a mixture of alumina and silica as the high surface area oxide support phase. The mixtures of alumina and silica retain higher surface area, after firing or exposure to elevated service temperatures, than does either component individually, and thereby impart higher overall surface area to the monolithic support structures.
Patent ES-8801380-A1 (ES)
Title: Stabilization of unstably inherited plasmids II.
IPC: C12N15/67
Filed: 1987-09-16
Abstract: The stable maintenance of a replicon in a population of growing cells is ensured by providing the replicon with a sequence which encodes a product capable of killing the cell harbouring the replicon or the progeny of the cell (or encodes a precursor for the product) and a sequence encoding an antagonist for the killing product (or a precursor for the antagonist). The antagonist is one which suppresses the killing product (or a precursor for the killing product) in cells harbouring the replicon, whereas the antagonist activity decays when the replicon is lost from the cell so that the antagonist (or its precursor) is no longer continuously expressed. This means that the killing product (or its precursor) present in the now replicon-free cell is no longer suppressed by the antagonist, resulting in cell death. Cells containing the thus stabilized replicon may be grown on a large scale without any significant loss of the replicon from the cell population even when no selection pressure is applied.
Patent IE-911807-A1 (IE)
Title: An exhaust gas removal system
IPC: F01N3/05
Filed: 1991-05-27
Abstract: In an exhaust gas conduit (10) having a device (13, 14) for purifying the exhaust gases, the arrangement of a cooling device (16) for the purified exhaust gases (17) is proposed. The cooling device is arranged in the exhaust gas line (12) in a suitable region downstream from the purification device (13, 14) in the flow direction. A heat exchanger (16) or a mixing device can be provided as the cooling device, by means of which cool environmental air can be supplied to the hot exhaust gases. In consequence, damage resulting from overheating, especially in the outlet region of the exhaust gases, is avoided.
Patent IE-912344-A1 (IE)
Title: Guanidines
Inventor: ACKERMANN JEAN
IPC: C07C279/12
Filed: 1991-07-04
Abstract: The novel guanidines of the formula 
<IMAGE>
 in which, L, M, R, T and X have the meaning given in the description, and hydrates or solvates thereof, inhibit thrombin-induced platelet aggregation and fibrinogen clotting in the plasma, are prepared by amidination, or by amide formation or esterification, depending on whether L is NH or O.
Patent IE-903610-A1 (IE)
Title: Treatment of hazardous waste material
IPC: A62D3/33
Filed: 1990-10-09
Abstract: Hazardous waste material is stabilized and rendered non-hazardous by mixing the waste with an alcohol component, and a surfactant component, and then binding such mixture in a cementitious matrix.
Patent IE-914423-A1 (IE)
Title: Novel compounds
IPC: C07H19/01
Filed: 1991-12-18
Abstract: Compounds of formula (I), wherein R<1> optionally protected hydroxy or methoxy, R<2> is hydrogen or 4'-( alpha -L-oleandrosyl)- alpha -L-oleandrosyloxy, and -Y- is a C1-3 alkylene group optionally substituted by one or more organic radicals, are useful in the treatment of helminthiasis.
Patent IE-921121-A1 (IE)
Title: GRF-Analogs II
Inventor: FELIX ARTHUR MARTIN
IPC: C07K14/575
Filed: 1992-04-08
Abstract: Novel growth hormone releasing factor analogs are presented having a sequence of twenty-nine to forty-four amino acids (SEQ ID NO: 6) wherein Xaa at position 1 is His, 3-MeHis, desNH2His, Tyr, or desNH2Tyr; Xaa at position 2 is Val, Leu, Ile, Ala, D-Ala, N-Methyl-D-Ala, Gly, Nle, or Nval; Xaa at position 8 is Gln, Ser, or Thr; Xaa at position 15 is Ala or Leu; Xaa at position 27 is Met, Nle or Leu; Xaa at position 28 is Ser or Asn; Xaa at position 29 is an amino acid residue sequence (SEQ ID NO: 7) or fragments thereof where the fragment is reduced in number by one to fifteen amino acid residues from the carboxyl-terminus, where the carboxyl terminus can be the free carboxylic acid or the corresponding amide, and the pharmaceutically acceptable acid or base addition salts thereof. The novel growth hormone releasing factor analogs have enhanced potency for the release of growth hormone and enzymatic stability, improved half-life stability in aqueous solution, and can be administered to a subject having a deficiency of growth hormone or for improvement of growth performance in livestock and other warm blooded animals and in fish and other cold blooded marine animals.
Patent IE-921641-A1 (IE)
Title: Process and intermediate for the preparation of isoquinoline¹derivatives
Inventor: MALAMAS MICHAEL SOTIRIOS
IPC: C07D217/26
Filed: 1992-07-01
Abstract: The invention presents a process for the preparation of spiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones which are useful as aldose reductase inhibitors and have the formula II <CHEM> where R<1> is hydrogen or halogen and R<2> is methyl or dihalogen-substituted benzyl. The process comprises a three step method from 1,2,3,4-tetrahydro-1,3-dioxo-4-isoquinolinecarboxylic acid esters via the 4-(cyanomethyl) and 4-(2-amino-2-oxoethyl) derivatives thereof.
Patent SU-1118880-A1 (SU)
Title: Способ А.И.Шпаковского определени степени герметичности системы
Inventor: SHPAKOVSKIJ ALEKSANDR I
IPC: G01M3/24
Filed: 1961-01-21
Granted: 1984-10-15
Abstract: Способ определени  степени герметичности  системы, наход щейс  под  давлением, заключающийс  в регистрации  акустических колебаний, возникающих  при истечении среды, от л и-,  ч а ю ц и и с   тем, что, с целью  упрощени , акустический датчик закрепл ют  на исследуемом объекте и  измер ют частоту и интенсивность  акустических колебаний.
Patent AT-520661-A1 (AT)
Title: Thermodynamische Maschine mit Ackeret-Keller Kreisprozess
Inventor: OTTO HEIN
IPC: F02C1/10
Filed: 2017-11-24
Abstract: Die vorliegende Erfindung betrifft eine thermodynamische Maschine, die zwischen zwei Wärmereservoiren nach dem Ackeret-Keller Kreisprozess arbeitet. Die Maschine kann sowohl als Wärmekraft- (Rechtsprozess) als auch als Kraftwärme-Maschine (Linksprozess) betrieben werden und erreicht einen hohen thermischen Wirkungsgrad. Erfindungsgemäß werden als Verdichter des gasförmigen Fluids mehrstufige Radialverdichter und als Expander mehrstufige Radialturbinen verwendet. Der prozesskonforme Wärmetransport zwischen dem Fluid und dem jeweiligen Wärmereservoir erfolgt mittels Wärmerohre, die als ,,heat pipes" oder nach dem 2-phasen Thermosiphon Prinzip ausgebildet sind. Bei der Verwendung als Wärmekraftmaschine erfolgt die Änderung der Leistung bei annähernd gleicher Drehzahl, gleichbleibendem Druck- und Temperaturverhältnis durch Erhöhen bzw. Verringern des Massenstroms des Fluids. Dadurch kann die Maschine für einen optimalen Betriebspunkt ausgelegt werden und erreicht dann einen hohen Gesamtwirkungsgrad.
Patent WO-8701780-A1 (WO)
Inventor: LECHNER HUBERT
IPC: F16H21/44
Filed: 1986-09-19
Abstract: Un dispositif à engrenages (1) comprend une tige dentée (4) agencée dans le rouleau cylindrique (2) d'un vérin pneumatique (3) et portant à ses deux extrémités des pistons (21, 22) étroitement adaptés dans le rouleau cylindrique (2). Le rouleau cylindrique (2) qui sert de tige directrice pivote autour de l'axe (8) de la roue dentée fixe (5) et une roue dentée mobile (11) est montée de façon pivotable sur le rouleau cylindrique (2) à une certaine distance de la roue dentée fixe (5). Une bielle oscillante (14) est reliée de façon non rotative à la roue dentée mobile (11). Les deux roues dentées (5, 11) pénètrent dans des fentes (17, 18) du rouleau cylindrique (2) du vérin pneumatique (3) de façon à enclencher la tige dentée (4). Lors d'un guidage droit, la distance entre les axes géométriques (8', 12') des deux roues dentées (5, 11) est égal à la longueur de la bielle oscillante (14) et le rayon de la roue dentée fixe (5) est deux fois plus grand que le rayon de la roue dentée mobile (11).
Patent WO-9405482-A1 (WO)
Inventor: PUERSTINGER FRANZ
IPC: B29C48/90
Filed: 1993-09-01
Abstract: The invention concerns an extruder (4) for components (2) with a cavity (26), in particular plastic components. The extruder has an internal cooling device (27) which is located downstream of the extrusion-nozzle slit (21) and which surrounds supply lines (29, 30) which pass down the centre (42) of the extruder (4), in particular in the vicinity of the nozzle slit (21), and terminate in the cavity (26) in the component (2), the supply lines being designed to supply a coolant (36) to the cavity (26) in the component (2). A heat exchanger (28) is fitted in the extruder at a certain distance from the nozzle slit (21) in the extrusion direction (arrow 5). The coolant (36) flows through the heat exchanger. Fitted in the cavity (26) in the component (2) is, in addition, a device (44) for circulating a cooling agent (46), in particular a gas.
Patent WO-0165199-A1 (WO)
Title: Douille de cartouche et cartouche pour trous de mine et procede d'utilisation
Inventor: TOTA EDWARD
IPC: F42B3/00
Filed: 2001-02-22
Abstract: Cartouche (10c) composée d'un corps (12) définissant un volume servant à contenir un matériau explosif. Ce corps (12) possède une première extrémité (16) contiguë au fond (48) du trou (46) creusé dans un matériau dur (47), et une deuxième extrémité (18) dirigée vers le pourtour (50) de l'ouverture du trou (46). L'extrémité (18) se rétrécit de manière à présenter une forme pointue ou conique. Un matériau de bourrage (52) est placé dans le trou (46) à un niveau situé au-dessous de la face découverte (54) du matériau dur (47), et est maintenu en place sous l'effet mécanique exercé par une tige de bourrage (56). A la mise à feu du matériau explosif, la pression du gaz pousse la cartouche (10c) vers le pourtour (50). La pointe joue un rôle simultané d'augmentation de la force de compression radiale sur le matériau de bourrage (52) dans la zone annulaire située entre l'extrémité (18) et la partie contiguë du trou (46). Ceci permet d'augmenter l'effet d'obturation du matériau de bourrage (52) et de conserver la constance du volume du trou (46) dans lequel le gaz exerce son action.
Patent WO-02077033-A1 (WO)
Title: Anticorps contre le cancer
Inventor: MCKENZIE IAN FARQUAR CAMPBELL
IPC: C12P21/08
Filed: 2002-03-26
Abstract: L'invention concerne un partenaire de liaison isolé d'une protéine Cripto-1, d'une protéine Pim-1 ou d'un antigène présent dans un lysat de cellule cancéreuse du côlon. Ce partenaire de liaison empêche la croissance d'au moins un typer de cellule cancéreuse et peut être utilisé dans un agent anticancéreux pour soigner le cancer chez un sujet. Ce partenaire de liaison peut également être utilisé dans un procédé de déclenchement de l'apoptose dans une cellule cancéreuse, ainsi que dans un procédé de sensibilisation d'une cellule cancéreuse à un composé cytotoxique. En outre, l'invention concerne un vaccin contre le cancer qui comprend une protéine Cripto-1 (ou un fragment antigénique de celle-ci), une protéine Pim-1 (ou un fragment antigénique de celle-ci) ou un antigène présent dans un lysat de cellule cancéreuse du côlon ou, dans un autre mode de réalisation, qui comprend une molécule d'ADN pouvant être exprimée codant pour une protéine Cripto-1 (ou un fragment antigénique de celle-ci), une protéine Pim-1 (ou un fragment antigénique de celle-ci) ou un antigène présent dans un lysat de cellule cancéreuse du côlon.
Patent WO-03006434-A1 (WO)
Title: Complexes metalliques destines a etre utilises en boroneutrotherapie
Inventor: RENDINA LOUIS M
IPC: A61K45/06
Filed: 2002-07-10
Abstract: L'invention concerne un complexe métallique représenté par la formule (I): [(L)M-(X)-R]m-(carborane)n...(I) ou un sel thérapeutiquement acceptable dudit complexe métallique, caractérisé en ce que: M représente un métal sélectionné parmi les métaux de transition tardifs; L représente des groupes ligand, reliés chacun au métal de manière suffisante pour compléter la couche de coordination de l'atome, lesdits groupes ligand étant identiques ou différents et étant chacun, indépendamment, sélectionnés dans le groupe comprenant les halogénures; NR1R2R3 dans lequel R?1, R2 et R3¿ peuvent être identiques ou différents, et sont ou peuvent représenter un alkyle, aryle, ester, éther, carboxy ou alcoxy; carboxylate, dicarboxylate, pyridinyle, ou un certain nombre de groupes de ligand formant ensemble un système cyclique 2,2'-bipyridine,2,2':6,2''-terpyridine ou 1,10-phénanthroline; X représente une base de Lewis; R représente un groupe organique reliant la base de Lewis au fragment carborane; le carborane représentant un dicarba-dodécarborane de formule (C¿2?B10H10), ou un dérivé substitué ou fonctionnalisé de ce dernier; et m et n sont compris entre 1 et 4. Les complexes de l'invention, préparés avec l'isotope ?10¿B sont utilisés en boroneutrothérapie.
Patent WO-03018233-A1 (WO)
Title: Procede de production de pieces de metal en forme
Inventor: ROHAN PATRICK WILLIAM
IPC: B22D17/00
Filed: 2002-08-23
Abstract: L'invention porte sur un procédé de moulage par injection d'articles faits d'un alliage pouvant se présenter sous forme de phase primaire dendritique, consistant à injecter l'alliage au moins principalement à l'état liquide au niveau de la buse. L'alliage s'écoule sur une trajectoire reliant la buse à la cavité matrice délimitée par le moule sous forme de courant. On agit sur l'écoulement de manière à accroître le courant dans les zones transversales des sections le long de la trajectoire séparant l'extrémité d'entrée de l'extrémité de sortie, sur au moins une partie de la trajectoire d'écoulement. Cela accroît suffisamment le ralentissement du courant traversant cette zone, alors qu'il présente une vitesse suffisante à l'extrémité d'entrée, ce qui a pour effet de faire passer l'alliage de l'état au moins principalement liquide à l'état semi-solide dans lequel s'effectue le remplissage de la cavité matrice.
Patent WO-2004025484-A1 (WO)
Title: Ata device attachment system
Inventor: CAMERON PATRICK
IPC: G06F13/38
Filed: 2003-06-30
Abstract: The design of the present invention is to facilitate adding of Advanced Technology Attachment (ATA) devices to a computer system by using connection ports for easy access to the ATA bus. The invention comprises of technologies and incorporated functions that are based upon a system that enables; a co-existence and/or bypass of devices attached the ATA BUS such as ATA devices or other interface and peripheral controller technologies, Bus Redirection and Selection, IPL Boot Configuration manipulation, data security, and provision of system power to connecting devices. User definable settings and configurations external to the computer system, help to select and execute the incorporated functions, and aid connection to the ATA bus for ATA devices.
Patent AU-2002216906-A1 (AU)
Title: Methods and devices for the transversal displacement of folded products
Inventor: HILLEBRAND BERND ANTON
IPC: B65H29/40
Filed: 2001-11-06
Abstract: The invention relates to a device for the transversal displacement of folded products, each nth folded product being laterally offset by a value (x) in the bucket wheel (01), before being distributed in the production direction (D). This allows, for example, every second subsequent folded product to be separated from the production stream.
Patent AU-2001232497-A1 (AU)
Title: Improved water cleaning process
Inventor: AAREBROT EIVIND
IPC: C02F1/26
Filed: 2001-02-06
Abstract: Method and system for extraction of fat or oil-soluble components, e.g. PAH, NDP and/or BTX, from produced water being separated from an oil or gas plant. The method is characterized by injection of a liquid consisting of hydrocarbons from the oil or gas plant into the water flow, the injection liquid having a lower content of the oil soluble components than the original oil phase in equilibrium with the water, the injection liquid is atomized into the whole water phase and the water/hydrocarbon mixture is given a predetermined retention time thus to allow mass transferring of the oil soluble components from the water to the injection liquid, before the injection liquid is separated from the water in a separator, preferably a hydro cyclone, the injection liquid being adapted to the separators working range for pressure and temperature.
Patent AU-2001257516-A1 (AU)
Title: Low-viscosity polymeric colorants exhibiting high color strength characteristics
Inventor: XIA JUSONG
IPC: C09B69/04
Filed: 2001-05-03
Abstract: New and useful low viscosity polymeric colorant formulations are provided comprising extremely low amounts of viscosity modifiers that drastically reduce the overall viscosity of the resultant colorant formulation as compared with the viscosity of the colorants themselves. In such a manner, the resultant formulation facilitates the utilization of such polymeric colorants within certain coloring processes and methods requiring low viscosity formulations while simultaneously permitting substantial retention of the same high color strength characteristics of the unmodified colorants. Such an unexpected result thus permits production and utilization of a low viscosity formulation that does not sacrifice colorability to an appreciable degree for target substrates or media. The inventive formulations thus comprise any number of polymeric colorants, (i.e., oxyalkylenated colorants comprising at least one chromophore constituent and at least oxyalkylene chain) and at least one viscosity modifying agent possessing a dipole moment of between 1.0 and 5.0 and/or a flash point of from about -20° C. to about 180° C. Such a modifying agent provides a significant reduction in viscosity at low levels (to permit better pumpability of the desired colorants) with no appreciable differences in coloring performance within final target media, and facilitates removal of such modifiers during or after utilization. Methods of production, utilization, and products produced with such formulations and by such methods are also encompassed within this invention.